US BROKER MOVES: EL upgraded at Barclays; HUBS downgraded at Raymond James
The October 5 roundup reports brokerage upgrades, downgrades, and new coverage initiations, including multiple Vylor initiations and a VIRT rating listed unchanged.
News detail
UPGRADES Wells Fargo (WFC) upgraded from Equalweight to Overweight at Morgan Stanley; PT USD 102.00 VIRT (VIRT) upgraded from Neutral to Neutral at JPMorgan; PT USD 84.00 Texas Roadhouse (TXRH) upgraded from In Line to Outperform at Evercore ISI; PT USD 200.00 (prev. USD 220.00) Ryder System (R) upgraded from Neutral to Overweight at JPMorgan; PT USD 298.00 (prev. USD 296.00) Microsoft (MSFT) upgraded from Hold to Buy at Melius Harley-Davidson (HOG) upgraded from Neutral to Buy at Citi; PT USD 33.00 (prev. USD 31.00) Estee Lauder (EL) upgraded from Equalweight to Overweight at Barclays; PT USD 108.00 (prev. USD 97.00) DraftKings (DKNG) upgraded from Neutral to Buy at BofA Securities; PT USD 27.00 Cboe Global Markets (CBOE) upgraded from Hold to Buy at TD Cowen; PT USD 334.00 DOWNGRADES Sphere Entertainment (SPHR) downgraded from Buy to Hold at Craig-Hallum uniQure (QURE) downgraded from Overweight to Equalweight at Barclays; PT USD 28.00 (prev. USD 60.00) PTC (PTC) downgraded from Buy to Hold at Loop Capital O-I Glass (OI) downgraded from Buy to Neutral at UBS; PT USD 6.00 Millrose Properties (MRP) downgraded from Market Outperform to Market Perform at Citizens Mosaic (MOS) downgraded from Outperform to Sector Perform at RBC Capital; PT USD 25.00 (prev. USD 27.00) Intercontinental Exchange (ICE) downgraded from Buy to Hold at TD Cowen; PT USD 166.00 HubSpot (HUBS) downgraded from Outperform to Market Perform at Raymond James GlobalFoundries (GFS) downgraded from Outperform to Neutral at BNP Paribas Exane; PT USD 51.00 (prev. USD 80.00) Bristol-Myers Squibb (BMY) downgraded from Outperform to Market Perform at Leerink; PT USD 59.00 Align Technology (ALGN) downgraded from Outperform to In Line at Evercore ISI INITIATIONS Zentalis Pharmaceuticals (ZNTL) initiated Outperform at Leerink; PT USD 8.00 Vylor (VYLR) initiated Outperform at Mizuho; PT USD 84.00 Vylor (VYLR) initiated Buy at BofA Securities; PT USD 78.00 Vylor (VYLR) initiated Buy at Vertical Research Partners; PT USD 74.00 Vertiv (VRT) initiated Outperform at BMO Capital; PT USD 329.00 Stagwell (STGW) initiated Buy at Goldman Sachs; PT USD 13.00 Sable Offshore (SOC) initiated Outperform at William Blair Southern Missouri Bancorp (SMBC) initiated Market Perform at Hovde Group; PT USD 76.00 Revolution Medicines (RVMD) initiated Outperform at Leerink; PT USD 288.00 REGENXBIO (RGNX) initiated Outperform at Mizuho; PT USD 22.00 nVent Electric (NVT) initiated Outperform at BMO Capital; PT USD 212.00 Lumexa Imaging Holdings (LMRI) initiated Buy at Truist Securities; PT USD 18.00 Korsana Biosciences (KRSA) initiated Outperform at Wedbush; PT USD 44.00 Samsara (IOT) initiated Buy at Jefferies; PT USD 50.00 Genmab (GMAB) initiated Outperform at Leerink; PT USD 50.00 Exelixis (EXEL) initiated Market Perform at Leerink; PT USD 55.00 CalAmp (CAMP) initiated Outperform at Oppenheimer; PT USD 15.00 Avidia Bancorp (AVBC) initiated Outperform at Hovde Group; PT USD 26.00
Related stocks
36 stocksWhat do investors think?
StockNow uses AI to translate and analyze information and does not guarantee its accuracy or completeness.
